Digestive Diseases and Sciences

, Volume 50, Issue 3, pp 490–498 | Cite as

Butyrate-Induced Differentiation of Colon Cancer Cells Is PKC and JNK Dependent

  • Arkadiusz OrchelEmail author
  • Zofia Dzierżewicz
  • Beata Parfiniewicz
  • Ludmi↰a Weglarz
  • Tadeusz Wilczok


Butyric acid, a short–chain fatty acid physiologically present in human large gut, is derived from bacterial fermentation of complex carbohydrates. It has been shown to reduce the growth and motility of colon cancer cell lines and to induce cell differentiation and apoptosis. Apoptosis is considered a result of normal colonocyte terminal differentiation in vivo. The aim of this study was to characterize the cellular mechanisms regulating differentiation of colon cancer cells stimulated with sodium butyrate (NaB). The two human colon cancer cell lines Caco-2 and HT-29 were treated with NaB at physiologically relevant concentrations. Alkaline phosphatase (ALP) activity, a marker of colonocyte differentiation, was increased 48 hr after treatment with 1 mM NaB. Higher doses of NaB (5 and 10 mM) induced apoptosis of the cells and failed to stimulate the colonocyte differentiation. Therefore, we assumed that butyrate augments cell differentiation and induces apoptosis, acting via various intracellular mechanisms, and butyrate-mediated programmed cell death cannot be considered a consequence of colonocyte terminal differentiation. The effect of NaB on ALP activity was significantly attenuated in the presence of inhibitors of protein kinase C and JNK. Inhibition of MEK–ERK signal transduction pathways augmented the impact of butyrate on colonocyte differentiation. These results suggest that butyrate could influence the colonocyte differentiation via modulation of the activity of cellular protein kinases and signal transduction.


butyrate colon cancer differentiation apoptosis MAP kinase protein kinase C 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Gordon JI, Schmidt GH, Roth KA: Studies of intestinal stem cells using normal, chimeric, and transgenic mice. FASEB J 6:3039–3050, 1992PubMedGoogle Scholar
  2. 2.
    Kim YS, Gum JR, Ho SB, Deng G: Colonocyte differentiation and proliferation: overview and the butyrate-induced transcriptional regulation of oncodevelopmental placental-like alkaline phosphatase gene in colon cancer cells. In Short Chain Fatty Acids, Falk Symposium 73. HJ Binder, J Cummings, KH Soergel (eds). Dordrecht, Kluwer Academic Press, 1993, pp 119–134Google Scholar
  3. 3.
    Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493–501, 1992CrossRefPubMedGoogle Scholar
  4. 4.
    Hall PA, Coates PJ, Ansari B, Hopwood D: Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis. J Cell Sci 107:3569–3577, 1994PubMedGoogle Scholar
  5. 5.
    Sträter J, Koretz K, Günthert AR, Möller P: In situ detection of enterocytic apoptosis in normal colon mucosa and in familial adenomatous polyposis. Gut 37:819–825, 1995PubMedGoogle Scholar
  6. 6.
    Williams AC, Hague A, Elder DJE, Paraskeva C: In vitro models for studying colorectal carcinogenesis: cellular and molecular events including APC and Rb cleavage in the control of proliferation, differentietion and apoptosis. Biochim Biophys Acta 1288:F9–F19, 1996PubMedGoogle Scholar
  7. 7.
    Turowski GA, Rashid Z, Hong F, Madri JA, Basson MD: Glutamine modulates phenotype and stimulates proliferation in human colon cancer cell lines. Cancer Res 54:5974–5980, 1994PubMedGoogle Scholar
  8. 8.
    Basson MD, Turowski GA, Rashid Z, Hong F, Madri JA: Regulation of human colonic cell line proliferation and phenotype by sodium butyrate. Dig Dis Sci 41:1986–1993, 1996Google Scholar
  9. 9.
    Basson MD, Turowski G, Emenaker N: Regulation of human (Caco-2) intestinal epithelial cell differentiation by extracellular matrix protein. Exp Cell Res 225:301–305, 1996PubMedGoogle Scholar
  10. 10.
    Rognoni JB, Pichard V, Honore S, Rigot V, Lehmann M, Roccabianca M, Carles G, Luis J, Marvaldi J, Briand C: Convergent effects of growth factors, hormones, and fibronectin are necessary for the enterocyte differentiation of a colon adenocarcinoma cell line (HT29-D4). Differentiation 63:305–317, 1998CrossRefPubMedGoogle Scholar
  11. 11.
    Wolin MJ: Control of short chain volatile acid production in the colon. In Short Chain Fatty Acids, Falk Symposium 73. HJ Binder, J Cummings, KH Soergel (eds). Dordrecht, Kluwer Academic Press, 1993, pp 3–10Google Scholar
  12. 12.
    Roediger WEW: Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 21:793–798, 1980PubMedGoogle Scholar
  13. 13.
    Roediger WE: Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology 83:424–429, 1982PubMedGoogle Scholar
  14. 14.
    Kripke SA, Fox AD, Berman JM, Settle RG, Rombeau JL: Stimulation of intestinal mucosal growth with intracolonic infusion of short-chain fatty acids. J Parent Enteral Nutr 13:109–116, 1989Google Scholar
  15. 15.
    Hass R, Busche R, Luciano L, Reale E, Engelhardt WV: Lack of butyrate is associated with induction of Bax and subsequent apoptosis in the proximal colon of guinea pig. Gastroenterology 112:875–881, 1997PubMedGoogle Scholar
  16. 16.
    Young GP, Gibson PR: Butyrate and the colorectal cancer cell. In Short Chain Fatty Acids, Falk Symposium 73. HJ Binder, J Cummings, KH Soergel (eds). Kluwer Academic Press, Dordrecht, 1993, pp 148–160Google Scholar
  17. 17.
    Dzierzewicz Z, Kwapisz I, Cwalina B, Wilczok T: The role of butyric acid in growth, proliferation and differentiation of colonocytes. Gastroenterol Pol 6:153–159, 1999Google Scholar
  18. 18.
    D’Argerio G, Cosenza V, Delle Cave M, Iovino P, DellaValle N, Lombardi G, Mazzacca G: Butyrate enemas in experimental colitis and protection against large bowel cancer in a rat model. Gastroenterology 110:1727–1734, 1996Google Scholar
  19. 19.
    Medina V, Afonso JT, Alverez-Arguelles H, Hernandez C, Gonzales F: Sodium butyrate inhibits carcinoma development in a 1,2-dimethylhydrazine–induced rat colon cancer. J Parent Enteral Nutr 22:14–17, 1998Google Scholar
  20. 20.
    Gamet L, Daviaud D, Denis-Pouxviel C, Remesy C, Murat JC: Effects of short-chain fatty acids on growth and differentiation of the human colon-cancer cell line HT29. Int J Cancer 52:286–289, 1992PubMedGoogle Scholar
  21. 21.
    Heerdt BG, Houston MA, Augenlicht LH: Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines. Cancer Res 54:3288–3293, 1994PubMedGoogle Scholar
  22. 22.
    Hague A, Elder DJ, Hicks DJ, Paraskeva C: Apoptosis in colorectal tumour cells: induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate. Int J Cancer 60:400–406, 1995PubMedCrossRefGoogle Scholar
  23. 23.
    Ruemmele FM, Dionne S, Qureshi I, Sarma DS, Levy E, Seidman EG: Butyrate mediates Caco-2 cell apoptosis via up-regulation of pro-apoptotic BAK and inducing caspase-3 mediated cleavage of poly-(ADP-ribose) polymerase (PARP). Cell Death Differ 6:729–735, 1999CrossRefPubMedGoogle Scholar
  24. 24.
    Mandal M, Olson DJ, Sharma T, Vadlamudi RK, Kumar R: Butyric acid induces apoptosis by up-regulating Bax expression via stimulation of the c-Jun N-terminal kinase/activation protein-1 pathway in human colon cancer cells. Gastroenterology 120:71–78, 2001PubMedGoogle Scholar
  25. 25.
    Dzierewicz Z, Orchel A, Wceglarz L, Latocha M, Wilczok T: Changes in the cellular behaviour of human colonic cell line Caco-2 in response to butyrate treatment. Acta Biochim Pol 49:211–220, 2002Google Scholar
  26. 26.
    Chung YS, Song IS, Erickson RH, Sleisenger MH, Kim YS: Effect of growth and sodium butyrate on brush border membrane-associated hydrolases in human colorectal cancer cell lines. Cancer Res 45:2976–2982, 1985PubMedGoogle Scholar
  27. 27.
    Gum JR, Kam WK, Byrd JC, Hicks JW, Sleisenger MH, Kim YS: Effects of sodium butyrate on human colonic adenocarcinoma cells. Induction of placental-like alkaline phosphatase. J Biol Chem 262:1092–1097, 1987Google Scholar
  28. 28.
    Tsao D, Morita A, Bella A Jr, Luu P, Kim YS: Differential effects of sodium butyrate, dimethyl sulfoxide, and retinoic acid on membrane-associated antigen, enzymes, and glycoproteins of human rectal adenocarcinoma cells. Cancer Res 42:1052–1058, 1982PubMedGoogle Scholar
  29. 29.
    Gibson PR, Rosella O, Wilson AJ, Mariadason JM, Rickard K, Byron K, Barkla DH: Colonic epithelial cell activation and the paradoxical effects of butyrate. Carcinogenesis 20:539–544, 1999PubMedGoogle Scholar
  30. 30.
    Weglarz L, Dzierzewicz Z, Orchel A, Szczerba J, Jaworska-Kik M, Wilczok T: Biological activity of Desulfovibrio desulfuricans lipopolysaccharides evaluated via interleukin-8 secretion by Caco-2 cells. Scand J Gastroenterol 38:73–79, 2003PubMedGoogle Scholar
  31. 31.
    Archer SY, Hodin RA: Histone acetylation and cancer. Curr Opin Genet Dev 9:171–174, 1999CrossRefPubMedGoogle Scholar
  32. 32.
    Archer SY, Meng S, Shei A, Hodin RA: p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells. Proc Natl Acad Sci USA 95:6791–6796, 1998PubMedGoogle Scholar
  33. 33.
    Litvak DA, Evers BM, Hwang KO, Hellmich MR, Ko TC, Townsend CM Jr: Butyrate-induced differentiation of Caco-2 cells is associated with apoptosis and early induction of p21Waf1/Cip1 and p27Kip1. Surgery 124:161–169, 1998PubMedGoogle Scholar
  34. 34.
    Schwartz B, Avivi-Green C, Polak-Charcon S: Sodium butyrate induces retinoblastoma protein dephosphorylation, p16 expression and growth arrest of colon cancer cells. Mol Cell Biochem 188:21–30, 1998PubMedGoogle Scholar
  35. 35.
    Orchel A, Molin I, Dzierzewicz Z, Latocha M, Weglarz L, Wilczok T: Quantification of p21 gene expression in Caco-2 cells treated with sodium butyrate using real-time reverse transcription-PCR (RT-PCR) assay. Acta Pol Pharm 60:103–105, 2003PubMedGoogle Scholar
  36. 36.
    Aihara H, Asaoka Y, Yoshida K, Nishizuka Y: Sustained activation of protein kinase C is essential to HL-60 cell differentiation to macrophage. Proc Natl Acad Sci USA 88:11062–11066, 1991PubMedGoogle Scholar
  37. 37.
    Murray NR, Baumgardner GP, Burns DJ, Fields AP: Protein kinase C isotypes in human erythroleukemia (K562) cell proliferation and differentiation. Evidence that βII protein kinase C is required for proliferation. J Biol Chem 268:15847–15853, 1993PubMedGoogle Scholar
  38. 38.
    Basson MD, Hong F, Emenaker NJ: Specific modulation of intestinal epithelial brush border enzyme expression by a phorbol ester. J Surg Res 59:121–126, 1995PubMedGoogle Scholar
  39. 39.
    Rickard KL, Gibson PR, Young GP, Phillips WA: Activation of protein kinase C augments butyrate-induced differentiation and turnover in human colonic epithelial cells in vitro. Carcinogenesis. 20:977–984, 1999PubMedGoogle Scholar
  40. 40.
    Rickard KL, Gibson PR, Wilson NJ, Mariadason JM, Phillips WA: Short-chain fatty acids reduce expression of specific protein kinase C isoforms in human colonic epithelial cells. J Cell Physiol 182:222–231, 2000PubMedGoogle Scholar
  41. 41.
    Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH: Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22:153–183, 2001CrossRefPubMedGoogle Scholar
  42. 42.
    Mamajiwalla SN, Burgess DR: Differential regulation of the activity of the 42 kD mitogen activated protein kinase (p42mapk) during enterocyte differentiation in vivo. Oncogene 11:377–386, 1995PubMedGoogle Scholar
  43. 43.
    Taupin D, Podolsky DK: Mitogen-activated protein kinase activation regulates intestinal epithelial differentiation. Gastroenterology 116:1072–1080, 1999PubMedGoogle Scholar
  44. 44.
    Luongo D, Mazzarella G, Della RF, Maurano F, Rossi M: Down-regulation of ERK1 and ERK2 activity during differentiation of the intestinal cell line HT-29. Mol Cell Biochem 231:43–50, 2002PubMedGoogle Scholar
  45. 45.
    Ding Q, Wang Q, Evers BM: Alterations of MAPK activities associated with intestinal cell differentiation. Biochem Biophys Res Commun 284:282–288, 2001PubMedGoogle Scholar
  46. 46.
    Avivi-Green C, Polak-Charcon S, Madar Z, Schwartz B: Different Molecular Events Account for Butyrate-Induced Apoptosis in Two Human Colon Cancer Cell Lines. J Nutr 132:1812–1818, 2002PubMedGoogle Scholar
  47. 47.
    Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254, 1976CrossRefPubMedGoogle Scholar
  48. 48.
    Pinto M, Robine-Leon S, Appay MD, Kerdinger M, Triadou N, Dussaulx E, Lacroix B, Simon-Assmann P, Haffen K, Fogh J, Zweibaum A: Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol Cell 47:323–330, 1983Google Scholar
  49. 49.
    Matsumoto H, Erickson RH, Gum JR, Yoshioka M, Gum E, Kim YS: Biosynthesis of alkaline phosphatase during differentiation of the human colon cancer cell line Caco-2. Gastroenterology 98:1199–2107, 1990PubMedGoogle Scholar
  50. 50.
    Huet C, Sahuquillo-Merino C, Coudrier E, Louvard D: Absorptive and mucus-secreting subclones isolated from a multipotent intestinal cell line (HT-29) provide new models for cell polarity and terminal differentiation. J Cell Biol 105:345–357, 1987PubMedGoogle Scholar
  51. 51.
    Herz F, Schermer A, Halwer M, Bogart LH: Alkaline phosphatase in HT-29, a human colon cancer cell line: influence of sodium butyrate and hyperosmolality. Arch Biochem Biophys 210:581–591, 1981PubMedGoogle Scholar
  52. 52.
    Gaschott T, Stein J: Tributyrin, a stable and rapidly absorbed prodrug of butyric acid, enhances antiproliferative effects of dihydroxycholecalciferol in human colon cancer cells. J Nutr 131:1839–1843, 2001PubMedGoogle Scholar
  53. 53.
    Ruemmele FM, Schwartz S, Seidman EG, Dionne S, Levy E, Lentze MJ: Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway. Gut 52:94–100, 2003PubMedGoogle Scholar
  54. 54.
    Nishizuka Y: Discovery and prospect of protein kinase C research: epilogue. J Biochem 133:155–158, 2003PubMedGoogle Scholar
  55. 55.
    Cerda SR, Bissonnette M, Scaglione-Sewell B, Lyons MR, Khare S, Mustafi R, Brasitus TA: PKC-delta inhibits anchorage-dependent and -independent growth, enhances differentiation, and increases apoptosis in CaCo-2 cells. Gastroenterology 120:1700–1712, 2001PubMedGoogle Scholar
  56. 56.
    Witt O, Schulze S, Kanbach K, Roth C, Pekrun A: Tumor cell differentiation by butyrate and environmental stress. Cancer Lett 171:173–182, 2001PubMedGoogle Scholar
  57. 57.
    Mariadason JM, Velcich A, Wilson AJ, Augenlicht LH, Gibson PR: Resistance to butyrate-induced cell differentiation and apoptosis during spontaneous Caco-2 cell differentiation. Gastroenterology 120:889–899, 2001PubMedGoogle Scholar
  58. 58.
    Bursch W, Paffe S, Putz B, Barthel G, Schulte-Hermann R: Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. Carcinogenesis 11:847–853, 1990PubMedGoogle Scholar
  59. 59.
    Santini V, Scappini B, Gozzini A, Grossi A, Villa P, Ronco G, Douillet O, Pouillart P, Bernabei PA, Rossi Ferrini P: Butyrate-stable monosaccharide derivatives induce maturation and apoptosis in human acute myeloid leukaemia cells. Br J Haematol 101:529–538, 1998PubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  • Arkadiusz Orchel
    • 1
    • 5
    Email author
  • Zofia Dzierżewicz
    • 1
  • Beata Parfiniewicz
    • 2
  • Ludmi↰a Weglarz
    • 3
  • Tadeusz Wilczok
    • 4
  1. 1.Departments of BiopharmacyMedical University of SilesiaSosnowiecPoland
  2. 2.Departments of BiochemistryMedical University of SilesiaSosnowiecPoland
  3. 3.Departments of Molecular Biology and GeneticsMedical University of SilesiaSosnowiecPoland
  4. 4.Departments of Biochemistry, and Molecular Biology and GeneticsMedical University of SilesiaSosnowiecPoland
  5. 5.Department of BiopharmacyMedical University of SilesiaSosnowiecPoland

Personalised recommendations